Vmbook Online ordering

Prophase Labs Inc

Prophase Labs, Inc. (PRPH) is a biotechnology company that focuses on the research, development, and commercialization of over-the-counter (OTC) drugs and dietary supplements. The company's lead product is Cold-Eeze®, a cold remedy based on the active ingredient zinc gluconate glycine.

When it comes to key financial metrics such as earnings and growth, it's important to note that Prophase Labs has experienced mixed financial results in recent years. For the fiscal year ended December 31, 2020, the company reported net sales of $12.2 million, compared to $15.4 million in the prior year. This represents a decline of approximately 20% in net sales. The company reported a net loss of $1.1 million, or $0.05 per diluted share, for the year ended December 31, 2020.

In terms of growth, Prophase Labs has faced challenges in recent years due to the highly competitive nature of the OTC drug and dietary supplement markets. However, the company has made efforts to expand its product line and reach new customers through various sales and marketing initiatives.

It is recommended to conduct thorough research or consult with a financial advisor before making any investment decisions, as the financial performance of individual companies can vary and the stock market can be unpredictable. It's also important to consider other factors such as the overall economic and market conditions, the competitive landscape, and the company's strategic initiatives.